spacer
Mental Health
topleft topright
space Consumers spacer Family spacer Advocates spacer Students spacer Careers space
bottomleft bottomright
topright
strip-left
spacer
Find Services

space
MD | Health Monitoring
space
Line Separator
space

Home » Medical Director » Health Monitoring

These documents are intended to serve as an educational and reference resource for behavioral health prescribers and clinical administrators and can be used for the development and update of policies and procedures related to therapeutic, safety, and health monitoring of behavioral health patients.

Health Monitoring Memo from Dr. Stone

Documents Available for Download:
  1. Summary Documents
    1. Summary Table For Adult Patients – Table containing comprehensive information on suggested measures for general health monitoring, therapeutic, and drug safety monitoring
    2. Health Monitoring ConsensusPhysical Health Monitoring of Patients with Schizophrenia, Am J Psychiatry 2004; 161:1334–1349.
    3. ADA – APA Consensus - Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes, Diabetes Care, 2004; 27 (2): 596-601
  2. Guidelines and Practice Parameters
    1. Practice Parameters For the Use of Atypical Antipsychotics In Children – AACP document
    2. Practice Parameter on the Use of Psychotropic Medication in Children and Adolescents – AACP Document
    3. First- and Second-Generation Antipsychotics for Children and Young Adults – Comparative effectiveness study from the Agency for Healthcare Research and Quality (AHRQ)
    4. Appropriate Use of Psychotropic Drugs in Children and Adolescents: A Clinical Monograph
  3. Tables and Tools
    1. Abnormal Involuntary Movement Scale (AIMS)
    2. Antipsychotic Medication Reference Tables – A set of tables with extensive information related to antipsychotic dosing, side effects, etc.
    3. BMI Reference Table
    4. Criteria for Metabolic Syndrome
    5. Key Characteristics of Mood Stabilizers
  4. Journal Articles
    1. Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population
    2. Antidepressant-Induced Liver Injury: A Review for Clinicians
    3. Therapeutic Drug Monitoring of Mood Stabilizers in Medicaid Patients with Bipolar Disorder
    4. Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs
    5. Short-Term Use of Serotonin Reuptake Inhibitors and Risk of Upper Gastrointestinal Bleeding
    6. Economic Costs of Failure to Monitor Adverse Effects of Second-Generation Antipsychotics: An Underestimated Factor
    7. Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study
    8. Rechallenging With Clozapine Following Neutropenia: Treatment Options for Refractory Schizophrenia
topleft topright
Site Contents A to Z
Press
Media Center
Events Calendar
Mental Health History
Advocacy Services
Nursing Home Screening (OBRA PASRR)
Deaf Services
Staff Development & Training
Nurse Delegation Program
Becoming a Community Provider
Contracts & Vendor Opportunities
bottomleft bottomright
strip-right
corner-bot-left corner-bot-right